Short-term effects of ouabain on energy-rich, glycolytic and citric-acid-cycle intermediates in frog heart.
D000227:Adenine Nucleotides / Q000378:metabolism; D000818:Animals; D001001:Anura; D002952:Citric Acid Cycle / Q000187:drug effects; D003201:Computers; D003401:Creatine / Q000378:metabolism; D005260:Female; D005947:Glucose / Q000378:metabolism; D005994:Glycerophosphates / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects*; D006600:Hexosephosphates / Q000378:metabolism; D066298:In Vitro Techniques; D007656:Ketoglutaric Acids / Q000378:metabolism; D007773:Lactates / Q000378:metabolism; D008293:Malates / Q000378:metabolism; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D010042:Ouabain / Q000494:pharmacology*; D010071:Oxaloacetates / Q000378:metabolism; D010710:Phosphates / Q000378:metabolism; D010725:Phosphocreatine / Q000378:metabolism; D011773:Pyruvates / Q000378:metabolism
D000227:Adenine Nucleotides; D005994:Glycerophosphates; D006600:Hexosephosphates; D007656:Ketoglutaric Acids; D007773:Lactates; D008293:Malates; D010071:Oxaloacetates; D010710:Phosphates; D011773:Pyruvates; D010725:Phosphocreatine; D010042:Ouabain; D005947:Glucose; D003401:Creatine